Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
2(40%)
Results Posted
100%(1 trials)
Terminated
1(20%)

Phase Distribution

Ph phase_4
1
20%
Ph phase_2
1
20%
Ph not_applicable
3
60%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
3(60.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(1)
Terminated(2)

Detailed Status

Recruiting2
Completed1
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (20.0%)
Phase 41 (20.0%)
N/A3 (60.0%)

Trials by Status

completed120%
recruiting240%
terminated120%
withdrawn120%

Recent Activity

Clinical Trials (5)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
5